These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 39084066)

  • 21. Serum IL-18 as a potential specific marker for differentiating systemic juvenile idiopathic arthritis from incomplete Kawasaki disease.
    Takahara T; Shimizu M; Nakagishi Y; Kinjo N; Yachie A
    Rheumatol Int; 2015 Jan; 35(1):81-4. PubMed ID: 24917023
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association of IL-10 gene polymorphisms and susceptibility to Juvenile Idiopathic Arthritis in Egyptian children and adolescents: a case-control study.
    Fathy MM; Elsaadany HF; Ali YF; Farghaly MA; Hamed ME; Ibrahim HE; Noah MA; Allah MA; Elashkar SS; Abdelsalam NI; Abdelrahman HM; Ahmed AR; Anany HG; Ismail SM; Ibrahim BR; Al Azizi NM; Gawish HH; Al-Akad GM; Nabil RM; Fahmy DS; Alsayed SF
    Ital J Pediatr; 2017 Jan; 43(1):9. PubMed ID: 28257625
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Juvenile idiopathic arthritis--clinical subgroups and classification].
    Minden K; Niewerth M
    Z Rheumatol; 2008 Mar; 67(2):100, 102-6, 108-10. PubMed ID: 18299857
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Extremely elevated IL-18 levels may help distinguish systemic-onset juvenile idiopathic arthritis from other febrile diseases.
    Xia Y; Cui P; Li Q; Liang F; Li C; Yang J
    Braz J Med Biol Res; 2017 Feb; 50(2):e5958. PubMed ID: 28225869
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Validation of the proposed ILAR classification criteria for juvenile idiopathic arthritis. International League of Associations for Rheumatology.
    Foeldvari I; Bidde M
    J Rheumatol; 2000 Apr; 27(4):1069-72. PubMed ID: 10782839
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum Leucine-Rich
    Shimizu M; Inoue N; Mizuta M; Nakagishi Y; Yachie A
    J Immunol Res; 2019; 2019():3140204. PubMed ID: 30863782
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Juvenile idiopathic arthritis in Jordan: single center experience.
    Alzyoud RM; Alsuweiti MO; Almaaitah HQ; Aladaileh BN; Alnoubani MK; Alwahadneh AM
    Pediatr Rheumatol Online J; 2021 Jun; 19(1):90. PubMed ID: 34118940
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Compensated inflammation in systemic juvenile idiopathic arthritis: role of alternatively activated macrophages.
    Shimizu M; Yachie A
    Cytokine; 2012 Oct; 60(1):226-32. PubMed ID: 22682876
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Influence of Matrix metalloproteinase 1 and 3 genetic variations on susceptibility and severity of juvenile idiopathic arthritis.
    Abd-Allah SH; El-Shal AS; Shalaby SM; Pasha HF; Abou El-Saoud AM; Abdel Galil SM; Mahmoud TA
    IUBMB Life; 2015 Dec; 67(12):934-42. PubMed ID: 26510114
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Soluble ST2 as a marker of disease activity in systemic juvenile idiopathic arthritis.
    Ishikawa S; Shimizu M; Ueno K; Sugimoto N; Yachie A
    Cytokine; 2013 May; 62(2):272-7. PubMed ID: 23561929
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Disease of the year: juvenile idiopathic arthritis-associated uveitis--classification and diagnostic approach.
    Tugal-Tutkun I; Quartier P; Bodaghi B
    Ocul Immunol Inflamm; 2014 Feb; 22(1):56-63. PubMed ID: 24410427
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum interleukin-18 level as a possible early diagnostic marker of systemic juvenile idiopathic arthritis.
    Souma K; Fujimura J; Nishiyama A; Oyazato Y; Kaneko S; Shimizu M; Morisawa T
    Int J Rheum Dis; 2023 Mar; 26(3):551-553. PubMed ID: 36527182
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum Calprotectin Levels in Different Subtypes of Juvenile Idiopathic Arthritis (JIA) and Its Correlation with Quantitative CRP and JADAS-27.
    Remthangpuii F; Maheshwari A; Gulati S; Sharma S; Mahto D; Chandra J
    Indian J Pediatr; 2023 Dec; 90(12):1177-1181. PubMed ID: 36763251
    [TBL] [Abstract][Full Text] [Related]  

  • 34. S100A12 is a novel molecular marker differentiating systemic-onset juvenile idiopathic arthritis from other causes of fever of unknown origin.
    Wittkowski H; Frosch M; Wulffraat N; Goldbach-Mansky R; Kallinich T; Kuemmerle-Deschner J; Frühwald MC; Dassmann S; Pham TH; Roth J; Foell D
    Arthritis Rheum; 2008 Dec; 58(12):3924-31. PubMed ID: 19035478
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Soluble CD163, a unique biomarker to evaluate the disease activity, exhibits macrophage activation in systemic juvenile idiopathic arthritis.
    Sakumura N; Shimizu M; Mizuta M; Inoue N; Nakagishi Y; Yachie A
    Cytokine; 2018 Oct; 110():459-465. PubMed ID: 29801971
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Change of diagnosis and diagnostic category in patients with juvenile idiopathic arthritis within 7 years of follow-up].
    Strickler AL; Cifuentes D; Mihovilovic K; Vergara F; Grez M; Rivera V
    Rev Chil Pediatr; 2020 Aug; 91(4):521-528. PubMed ID: 33399728
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluating treatment practices and challenges in systemic Juvenile Idiopathic Arthritis: a comprehensive survey analysis.
    Tan X; Zhao X; Deng J; Li C; Zhang J; Li S; Li C
    Clin Rheumatol; 2024 Nov; 43(11):3469-3475. PubMed ID: 39340571
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multicenter inception cohort of enthesitis-related arthritis: variation in disease characteristics and treatment approaches.
    Gmuca S; Xiao R; Brandon TG; Pagnini I; Wright TB; Beukelman T; Morgan EM; Weiss PF
    Arthritis Res Ther; 2017 May; 19(1):84. PubMed ID: 28464909
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cytokine profile in adult-onset Still's disease: Comparison with systemic juvenile idiopathic arthritis.
    Inoue N; Shimizu M; Tsunoda S; Kawano M; Matsumura M; Yachie A
    Clin Immunol; 2016 Aug; 169():8-13. PubMed ID: 27263804
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cross-cultural adaptation and psychometric evaluation of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) in 54 languages across 52 countries: review of the general methodology.
    Bovis F; Consolaro A; Pistorio A; Garrone M; Scala S; Patrone E; Rinaldi M; Villa L; Martini A; Ravelli A; Ruperto N;
    Rheumatol Int; 2018 Apr; 38(Suppl 1):5-17. PubMed ID: 29637323
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.